| UniProt ID | PRP19_HUMAN | |
|---|---|---|
| UniProt AC | Q9UMS4 | |
| Protein Name | Pre-mRNA-processing factor 19 {ECO:0000305} | |
| Gene Name | PRPF19 {ECO:0000312|HGNC:HGNC:17896} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 504 | |
| Subcellular Localization | Nucleus . Nucleus, nucleoplasm . Cytoplasm, cytoskeleton, spindle . Cytoplasm . Lipid droplet . Nucleoplasmic in interphase cells. Irregularly distributed in anaphase cells. In prophase cells, uniformly distributed, but not associated with condensing | |
| Protein Description | Ubiquitin-protein ligase which is a core component of several complexes mainly involved pre-mRNA splicing and DNA repair. Core component of the PRP19C/Prp19 complex/NTC/Nineteen complex which is part of the spliceosome and participates in its assembly, its remodeling and is required for its activity. During assembly of the spliceosome, mediates 'Lys-63'-linked polyubiquitination of the U4 spliceosomal protein PRPF3. Ubiquitination of PRPF3 allows its recognition by the U5 component PRPF8 and stabilizes the U4/U5/U6 tri-snRNP spliceosomal complex. [PubMed: 20595234 Recruited to RNA polymerase II C-terminal domain (CTD) and the pre-mRNA, it may also couple the transcriptional and spliceosomal machineries] | |
| Protein Sequence | MSLICSISNEVPEHPCVSPVSNHVYERRLIEKYIAENGTDPINNQPLSEEQLIDIKVAHPIRPKPPSATSIPAILKALQDEWDAVMLHSFTLRQQLQTTRQELSHALYQHDAACRVIARLTKEVTAAREALATLKPQAGLIVPQAVPSSQPSVVGAGEPMDLGELVGMTPEIIQKLQDKATVLTTERKKRGKTVPEELVKPEELSKYRQVASHVGLHSASIPGILALDLCPSDTNKILTGGADKNVVVFDKSSEQILATLKGHTKKVTSVVFHPSQDLVFSASPDATIRIWSVPNASCVQVVRAHESAVTGLSLHATGDYLLSSSDDQYWAFSDIQTGRVLTKVTDETSGCSLTCAQFHPDGLIFGTGTMDSQIKIWDLKERTNVANFPGHSGPITSIAFSENGYYLATAADDSSVKLWDLRKLKNFKTLQLDNNFEVKSLIFDQSGTYLALGGTDVQIYICKQWTEILHFTEHSGLTTGVAFGHHAKFIASTGMDRSLKFYSL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSLICSISN ------CCEEEECCC | 26.83 | 22223895 | |
| 2 | Phosphorylation | ------MSLICSISN ------CCEEEECCC | 26.83 | 28464451 | |
| 18 | Phosphorylation | VPEHPCVSPVSNHVY CCCCCCCCCCCCHHH | 26.71 | 25159151 | |
| 32 | Ubiquitination | YERRLIEKYIAENGT HHHHHHHHHHHHHCC | 34.66 | 29967540 | |
| 32 | Acetylation | YERRLIEKYIAENGT HHHHHHHHHHHHHCC | 34.66 | 26051181 | |
| 48 | Phosphorylation | PINNQPLSEEQLIDI CCCCCCCCHHHCEEE | 45.85 | 28348404 | |
| 56 | Ubiquitination | EEQLIDIKVAHPIRP HHHCEEEEECCCCCC | 29.62 | 29967540 | |
| 64 | Ubiquitination | VAHPIRPKPPSATSI ECCCCCCCCCCCCCH | 60.76 | 29967540 | |
| 64 | Acetylation | VAHPIRPKPPSATSI ECCCCCCCCCCCCCH | 60.76 | 26051181 | |
| 67 | Phosphorylation | PIRPKPPSATSIPAI CCCCCCCCCCCHHHH | 53.35 | 20068231 | |
| 69 | Phosphorylation | RPKPPSATSIPAILK CCCCCCCCCHHHHHH | 31.37 | 20068231 | |
| 70 | Phosphorylation | PKPPSATSIPAILKA CCCCCCCCHHHHHHH | 26.70 | 20068231 | |
| 86 | Sulfoxidation | QDEWDAVMLHSFTLR HHHHHHHHHHHHHHH | 2.74 | 30846556 | |
| 91 | Phosphorylation | AVMLHSFTLRQQLQT HHHHHHHHHHHHHHH | 24.85 | 24719451 | |
| 104 | Phosphorylation | QTTRQELSHALYQHD HHHHHHHHHHHHHHH | 13.13 | 28152594 | |
| 108 | Phosphorylation | QELSHALYQHDAACR HHHHHHHHHHHHHHH | 12.46 | 28152594 | |
| 114 | Glutathionylation | LYQHDAACRVIARLT HHHHHHHHHHHHHHH | 3.70 | 22555962 | |
| 122 | Acetylation | RVIARLTKEVTAARE HHHHHHHHHHHHHHH | 55.57 | 19608861 | |
| 122 | Ubiquitination | RVIARLTKEVTAARE HHHHHHHHHHHHHHH | 55.57 | 27667366 | |
| 133 | O-linked_Glycosylation | AAREALATLKPQAGL HHHHHHHHHCCCCCE | 35.84 | 23301498 | |
| 135 | Acetylation | REALATLKPQAGLIV HHHHHHHCCCCCEEC | 30.63 | 26051181 | |
| 148 | Phosphorylation | IVPQAVPSSQPSVVG ECCCCCCCCCCCCCC | 34.70 | 26714015 | |
| 148 | O-linked_Glycosylation | IVPQAVPSSQPSVVG ECCCCCCCCCCCCCC | 34.70 | 23301498 | |
| 149 | Phosphorylation | VPQAVPSSQPSVVGA CCCCCCCCCCCCCCC | 39.79 | 22529335 | |
| 149 | O-linked_Glycosylation | VPQAVPSSQPSVVGA CCCCCCCCCCCCCCC | 39.79 | 23301498 | |
| 152 | Phosphorylation | AVPSSQPSVVGAGEP CCCCCCCCCCCCCCC | 23.07 | 26714015 | |
| 152 | O-linked_Glycosylation | AVPSSQPSVVGAGEP CCCCCCCCCCCCCCC | 23.07 | 23301498 | |
| 169 | Phosphorylation | LGELVGMTPEIIQKL HHHHCCCCHHHHHHH | 16.31 | 26714015 | |
| 169 | O-linked_Glycosylation | LGELVGMTPEIIQKL HHHHCCCCHHHHHHH | 16.31 | 23301498 | |
| 179 | Acetylation | IIQKLQDKATVLTTE HHHHHHHHCEEEECH | 32.75 | 23749302 | |
| 179 | 2-Hydroxyisobutyrylation | IIQKLQDKATVLTTE HHHHHHHHCEEEECH | 32.75 | - | |
| 179 | Ubiquitination | IIQKLQDKATVLTTE HHHHHHHHCEEEECH | 32.75 | 29967540 | |
| 181 | Phosphorylation | QKLQDKATVLTTERK HHHHHHCEEEECHHH | 23.07 | 21406692 | |
| 184 | Phosphorylation | QDKATVLTTERKKRG HHHCEEEECHHHHCC | 23.44 | 28509920 | |
| 185 | Phosphorylation | DKATVLTTERKKRGK HHCEEEECHHHHCCC | 29.63 | 28509920 | |
| 192 | Malonylation | TERKKRGKTVPEELV CHHHHCCCCCCHHHC | 50.84 | 26320211 | |
| 192 | Ubiquitination | TERKKRGKTVPEELV CHHHHCCCCCCHHHC | 50.84 | 32015554 | |
| 193 | Phosphorylation | ERKKRGKTVPEELVK HHHHCCCCCCHHHCC | 44.08 | 22817900 | |
| 200 | Ubiquitination | TVPEELVKPEELSKY CCCHHHCCHHHHHHH | 60.37 | 24816145 | |
| 200 | Acetylation | TVPEELVKPEELSKY CCCHHHCCHHHHHHH | 60.37 | 26051181 | |
| 206 | Ubiquitination | VKPEELSKYRQVASH CCHHHHHHHHHHHHH | 58.01 | 29967540 | |
| 206 | Acetylation | VKPEELSKYRQVASH CCHHHHHHHHHHHHH | 58.01 | 23749302 | |
| 206 | 2-Hydroxyisobutyrylation | VKPEELSKYRQVASH CCHHHHHHHHHHHHH | 58.01 | - | |
| 212 | Phosphorylation | SKYRQVASHVGLHSA HHHHHHHHHHCCCCC | 21.61 | 28122231 | |
| 218 | Phosphorylation | ASHVGLHSASIPGIL HHHHCCCCCCCCCEE | 28.84 | 28122231 | |
| 220 | Phosphorylation | HVGLHSASIPGILAL HHCCCCCCCCCEEEE | 32.12 | 28348404 | |
| 236 | Acetylation | LCPSDTNKILTGGAD CCCCCCCCEECCCCC | 40.98 | 26051181 | |
| 236 | Ubiquitination | LCPSDTNKILTGGAD CCCCCCCCEECCCCC | 40.98 | 29967540 | |
| 239 | Phosphorylation | SDTNKILTGGADKNV CCCCCEECCCCCCCE | 36.72 | 22210691 | |
| 244 | Acetylation | ILTGGADKNVVVFDK EECCCCCCCEEEEEC | 51.62 | 23954790 | |
| 244 | Malonylation | ILTGGADKNVVVFDK EECCCCCCCEEEEEC | 51.62 | 26320211 | |
| 244 | Ubiquitination | ILTGGADKNVVVFDK EECCCCCCCEEEEEC | 51.62 | 23000965 | |
| 244 | 2-Hydroxyisobutyrylation | ILTGGADKNVVVFDK EECCCCCCCEEEEEC | 51.62 | - | |
| 251 | 2-Hydroxyisobutyrylation | KNVVVFDKSSEQILA CCEEEEECCHHHHHH | 44.40 | - | |
| 251 | Acetylation | KNVVVFDKSSEQILA CCEEEEECCHHHHHH | 44.40 | 25953088 | |
| 251 | Ubiquitination | KNVVVFDKSSEQILA CCEEEEECCHHHHHH | 44.40 | 29967540 | |
| 252 | Phosphorylation | NVVVFDKSSEQILAT CEEEEECCHHHHHHH | 40.74 | 22210691 | |
| 253 | Phosphorylation | VVVFDKSSEQILATL EEEEECCHHHHHHHH | 38.98 | 22210691 | |
| 259 | Phosphorylation | SSEQILATLKGHTKK CHHHHHHHHCCCCCE | 26.09 | 22210691 | |
| 261 | Acetylation | EQILATLKGHTKKVT HHHHHHHCCCCCEEE | 44.27 | 19608861 | |
| 261 | Ubiquitination | EQILATLKGHTKKVT HHHHHHHCCCCCEEE | 44.27 | 22817900 | |
| 261 | 2-Hydroxyisobutyrylation | EQILATLKGHTKKVT HHHHHHHCCCCCEEE | 44.27 | - | |
| 265 | Ubiquitination | ATLKGHTKKVTSVVF HHHCCCCCEEEEEEE | 39.30 | 22817900 | |
| 266 | Malonylation | TLKGHTKKVTSVVFH HHCCCCCEEEEEEEC | 52.48 | 26320211 | |
| 266 | Ubiquitination | TLKGHTKKVTSVVFH HHCCCCCEEEEEEEC | 52.48 | 22817900 | |
| 268 | Phosphorylation | KGHTKKVTSVVFHPS CCCCCEEEEEEECCC | 25.36 | 21406692 | |
| 269 | O-linked_Glycosylation | GHTKKVTSVVFHPSQ CCCCEEEEEEECCCC | 21.19 | 23301498 | |
| 269 | Phosphorylation | GHTKKVTSVVFHPSQ CCCCEEEEEEECCCC | 21.19 | 21406692 | |
| 275 | Phosphorylation | TSVVFHPSQDLVFSA EEEEECCCCCEEEEC | 27.96 | 21406692 | |
| 281 | O-linked_Glycosylation | PSQDLVFSASPDATI CCCCEEEECCCCCEE | 21.98 | 23301498 | |
| 281 | Phosphorylation | PSQDLVFSASPDATI CCCCEEEECCCCCEE | 21.98 | 21406692 | |
| 283 | Phosphorylation | QDLVFSASPDATIRI CCEEEECCCCCEEEE | 23.32 | 21406692 | |
| 287 | Phosphorylation | FSASPDATIRIWSVP EECCCCCEEEEEECC | 20.40 | 21406692 | |
| 297 | Phosphorylation | IWSVPNASCVQVVRA EEECCCCCEEEEEEH | 22.82 | 21712546 | |
| 307 | Phosphorylation | QVVRAHESAVTGLSL EEEEHHHCCCCCCEE | 20.40 | 18669648 | |
| 310 | Phosphorylation | RAHESAVTGLSLHAT EHHHCCCCCCEEEEC | 31.93 | 18669648 | |
| 313 | Phosphorylation | ESAVTGLSLHATGDY HCCCCCCEEEECCCE | 21.32 | 18669648 | |
| 329 | Phosphorylation | LSSSDDQYWAFSDIQ CCCCCCCEEEEECCC | 13.00 | 18669648 | |
| 342 | Phosphorylation | IQTGRVLTKVTDETS CCCCCEEEEEECCCC | 22.17 | 18669648 | |
| 343 | Acetylation | QTGRVLTKVTDETSG CCCCEEEEEECCCCC | 38.69 | 26051181 | |
| 375 | Ubiquitination | GTMDSQIKIWDLKER CCCCCEEEEEECHHC | 30.06 | 22817900 | |
| 380 | Acetylation | QIKIWDLKERTNVAN EEEEEECHHCCCCCC | 42.55 | 26822725 | |
| 380 | Succinylation | QIKIWDLKERTNVAN EEEEEECHHCCCCCC | 42.55 | 23954790 | |
| 380 | Ubiquitination | QIKIWDLKERTNVAN EEEEEECHHCCCCCC | 42.55 | 27667366 | |
| 380 | 2-Hydroxyisobutyrylation | QIKIWDLKERTNVAN EEEEEECHHCCCCCC | 42.55 | - | |
| 405 | Phosphorylation | IAFSENGYYLATAAD EEEECCCEEEEEECC | 13.59 | - | |
| 423 | Ubiquitination | VKLWDLRKLKNFKTL CCEEEHHHCCCCCEE | 71.73 | 22817900 | |
| 425 | Ubiquitination | LWDLRKLKNFKTLQL EEEHHHCCCCCEEEE | 64.47 | 22817900 | |
| 425 | Acetylation | LWDLRKLKNFKTLQL EEEHHHCCCCCEEEE | 64.47 | 25953088 | |
| 428 | Acetylation | LRKLKNFKTLQLDNN HHHCCCCCEEEECCC | 58.69 | 25953088 | |
| 428 | Malonylation | LRKLKNFKTLQLDNN HHHCCCCCEEEECCC | 58.69 | 32601280 | |
| 428 | Ubiquitination | LRKLKNFKTLQLDNN HHHCCCCCEEEECCC | 58.69 | 21906983 | |
| 495 | Sulfoxidation | KFIASTGMDRSLKFY HHHHCCCCCCCCEEE | 3.81 | 21406390 | |
| 500 | Ubiquitination | TGMDRSLKFYSL--- CCCCCCCEEECC--- | 43.43 | 24816145 | |
| 503 | Phosphorylation | DRSLKFYSL------ CCCCEEECC------ | 30.64 | 24719451 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRP19_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRP19_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-122 AND LYS-261, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; THR-310; SER-313;TYR-329 AND THR-342, AND MASS SPECTROMETRY. | |